M. Eng

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.

N. Kemeny, L. Saltz, A. Dietz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

L. Leong, S. Wilczynski, P. Frankel, 2018, Clinical Cancer Research.

Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design

M. Fakih, J. Jones, P. Frankel, 2022, Pleura and peritoneum.

Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.

N. Kemeny, G. Schwartz, L. Saltz, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in patients (Pts) with selected frα-positive solid tumors: Results in the ovarian cancer (EC) cohort.

Yi-Jen Chen, S. Wilczynski, P. Frankel, 2021 .

Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA

M. Fakih, P. Frankel, L. Rodriguez-Rodriguez, 2023, Annals of Surgical Oncology.